|
Characteristic
|
Total (n = 491)
|
UXT
|
P
|
|---|
|
High (n = 246)
|
Low (n = 245)
|
|---|
|
Gender
| | | |
P = 0.0006
|
|
Male
|
313
|
175
|
138
| |
|
Female
|
178
|
71
|
107
| |
|
Age
| | | |
P = 0.0643
|
|
≤60
|
242
|
111
|
131
| |
|
>60
|
249
|
135
|
114
| |
|
Mean (SD)
|
60.8 (12.1)
|
61.7 (12.1)
|
60.0 (12.0)
| |
|
Grade
| | | |
P = 0.0007
|
|
G1-G2
|
223
|
92
|
128
| |
|
G3-G4
|
267
|
153
|
114
| |
|
GX
|
3
|
1
|
3
| |
|
TNM Stage
| | | |
P = 0.0003
|
|
I-II
|
293
|
127
|
166
| |
|
III-IV
|
198
|
119
|
79
| |
|
T Stage
| | | |
P = 0.0023
|
|
T1-T2
|
210
|
139
|
171
| |
|
T3-T4
|
181
|
107
|
74
| |
|
Lymph node metastasis
| | | |
P = 0.6509
|
|
N0
|
220
|
108
|
112
| |
|
N1
|
14
|
6
|
8
| |
|
NX
|
258
|
132
|
126
| |
|
Distant metastasis
| | | |
P = 0.0431
|
|
M0
|
385
|
187
|
198
| |
|
M1
|
75
|
46
|
29
| |
|
MX
|
31
|
13
|
18
| |
|
Vital status
| | | |
P = 0.0009
|
|
Dead
|
163
|
99
|
64
| |
|
Alive
|
328
|
147
|
181
| |
- Two-tailed chi-square test was done with the SPSS software program to determine the statistical significance of the level of expression of UXT in different Clinical characteristics, P < 0.05 was considered significant
